Millennium Management
EVGN icon

Millennium Management’s Evogene EVGN Stock Holding History

Millennium Management’s Portfolio EVGN Stock Details EVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,407
Closed -$28.6K – 6282
2023
Q4 		$28.6K Buy
3,407
+2,042
+150% +$12.8K ﹤0.01% 5581
2023
Q3 		$7.99K Buy
+1,365
New +$12K ﹤0.01% 5798
2023
Q2 		– Sell
-7,861
Closed -$50K – 6246
2023
Q1 		$50K Buy
7,861
+6,178
+367% +$46K ﹤0.01% 5623
2022
Q4 		$12K Buy
1,683
+171
+11% +$1.21K ﹤0.01% 6155
2022
Q3 		$13K Buy
1,512
+345
+30% +$3.33K ﹤0.01% 6581
2022
Q2 		$9K Sell
1,167
-8,127
-87% -$79.5K ﹤0.01% 6690
2022
Q1 		$121K Sell
9,294
-5,015
-35% -$67.6K ﹤0.01% 6060
2021
Q4 		$235K Buy
+14,309
New +$325K ﹤0.01% 5770
2021
Q3 		– Sell
-7,267
Closed -$249K – 6901
2021
Q2 		$249K Sell
7,267
-21,935
-75% -$859K ﹤0.01% 5874
2021
Q1 		$1.47M Buy
+29,202
New +$1.81M ﹤0.01% 3819

Other funds holding EVGN

SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Millennium Management's EVGN Position: Q1 2024 in Review

Millennium Management sold out of Evogene (EVGN) in Q1 2024, closing a stake of 3,407 shares — an estimated $28.6K sold.

Millennium Management first reported a position in EVGN in Q1 2021 and held it in 10 quarters. The position peaked at $1.47M in Q1 2021. 29 funds tracked by Wall St. Rank hold EVGN as of Q1 2024.

  • Millennium Management reported no remaining Evogene position as of Q1 2024 after selling out during the quarter.
  • Millennium Management sold 3,407 Evogene shares in Q1 2024, an estimated $28.6K.
  • Millennium Management first reported a position in Evogene in Q1 2021 and held it in 10 quarters.
  • Millennium Management's Evogene position peaked at $1.47M in Q1 2021.
  • 29 funds tracked by Wall St. Rank held Evogene as of Q1 2024.

Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.